HTML Markup:

Confirmation Hearing Rescheduled to January 10, 2024

AUSTIN, Texas–(BUSINESS WIRE)–$CORZQ #bitcoin — Core Scientific, Inc. (OTC: CORZQ) (“Core Scientific” or the “Company”), a leader in high-performance blockchain computing data centers and software solutions, today announced it has reached an agreement in principle with all key stakeholders on the terms of a global settlement (the “Global Settlement”) of its Chapter 11 cases.

Summary

Core Scientific has reached a global settlement in its Chapter 11 cases, allowing the company to move forward with a reorganization plan. The settlement was reached with the Ad Hoc Noteholders Group, Unsecured Creditors Committee, Equity Committee, and B. Riley, the Company’s Debtor in Possession lender. The confirmation hearing for the plan has been rescheduled to January 10, 2024. In light of the settlement, the deadline for participating in the Equity Rights Offering has been extended to December 28, 2023.

Introduction

Core Scientific, a leader in high-performance blockchain computing data centers and software solutions, has announced a global settlement in its Chapter 11 cases. This settlement represents a significant milestone for the company, as it allows them to proceed with a consensual plan of reorganization and move towards confirmation and exit from Chapter 11.

Main Points

• The global settlement reached with key stakeholders paves the way for Core Scientific’s emergence from Chapter 11 in January 2024.
• Core Scientific’s CEO, Adam Sullivan, expressed excitement for the opportunities ahead in the new year, with a focus on operational excellence and continued growth.
• The combined hearing to consider final approval of the Disclosure Statement and confirmation of the Plan has been adjourned to January 10, 2024, to provide time for finalizing updates to the Chapter 11 Plan.
• The deadline for participating in the Equity Rights Offering has been extended to December 28, 2023, due to the settlement and adjournment of the hearing.

Conclusion

Core Scientific has achieved a significant milestone in its Chapter 11 cases with a global settlement reached with key stakeholders. This allows the company to move forward with its reorganization plan and sets the stage for its emergence from Chapter 11 in January 2024. The rescheduled confirmation hearing and extended deadline for the Equity Rights Offering provide additional time for finalizing the Chapter 11 Plan and allow stakeholders to participate in the offering. Core Scientific is optimistic about the opportunities that lie ahead in the new year.